Search research articles
Contact Us
Filters
Showing results (201-210 of 214) with videos related to
Page
of 22
Sort By:
Cancer Genetics
|
September 22, 2021
Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)
Nishwant Swami, William L Hwang, Jimmy A Guo, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Jeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
JCO Precision Oncology
|
January 20, 2022
Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate
William A Hall, Nick Fishbane, Yang Liu, et al.
European Urology
|
May 29, 2020
Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer
Amar U Kishan, Tahmineh Romero, Mohammed Alshalalfa, et al.
European Urology
|
December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
Neil K Jairath, Alan Dal Pra, Randy Vince, et al.
JAMA Network Open
|
December 29, 2021
Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis
Ting Martin Ma, Tahmineh Romero, Nicholas G Nickols, et al.
JAMA Oncology
|
May 24, 2019
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality
Robert T Dess, Holly E Hartman, Brandon A Mahal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 9, 2020
Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control
Rebecca G Levin-Epstein, Naomi Y Jiang, Xiaoyan Wang, et al.
JAMA Oncology
|
March 28, 2020
Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer
Robert T Dess, Yilun Sun, William C Jackson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 15, 2020
Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients
Rebecca Levin-Epstein, Ryan R Cook, J Karen Wong, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 214) with videos related to
Sort By:
Page
of 22
Cancer Genetics
|
September 22, 2021
Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)
Nishwant Swami, William L Hwang, Jimmy A Guo, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Jeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
JCO Precision Oncology
|
January 20, 2022
Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate
William A Hall, Nick Fishbane, Yang Liu, et al.
European Urology
|
May 29, 2020
Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer
Amar U Kishan, Tahmineh Romero, Mohammed Alshalalfa, et al.
European Urology
|
December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
Neil K Jairath, Alan Dal Pra, Randy Vince, et al.
JAMA Network Open
|
December 29, 2021
Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis
Ting Martin Ma, Tahmineh Romero, Nicholas G Nickols, et al.
JAMA Oncology
|
May 24, 2019
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality
Robert T Dess, Holly E Hartman, Brandon A Mahal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 9, 2020
Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control
Rebecca G Levin-Epstein, Naomi Y Jiang, Xiaoyan Wang, et al.
JAMA Oncology
|
March 28, 2020
Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer
Robert T Dess, Yilun Sun, William C Jackson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 15, 2020
Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients
Rebecca Levin-Epstein, Ryan R Cook, J Karen Wong, et al.
Page
of 22